Extracardiac malformations associated with congenital heart disease

European Journal of Cardiology
|March 1, 1978
PubMed

Insights

Extracardiac malformations are common in children with congenital heart disease, affecting nearly half of those studied. These anomalies significantly contributed to mortality, particularly in low birthweight infants.

Area of Science:

  • Pediatrics
  • Cardiology
  • Medical Genetics

Background:

  • Congenital heart disease (CHD) is a significant health concern in infants and children.
  • Extracardiac malformations (ECMs) frequently coexist with CHD, impacting patient outcomes.
  • Understanding the spectrum and impact of ECMs in CHD is crucial for comprehensive care.

Purpose of the Study:

  • To determine the incidence of significant extracardiac malformations in a cohort of 1000 children with CHD.
  • To analyze the association between ECMs and patient demographics, birthweight, and mortality.
  • To identify patterns of ECMs in relation to specific types of congenital heart lesions.

Main Methods:

  • Combined clinical and autopsy study of 1000 pediatric patients with CHD.
  • Data collection included patient demographics, birthweight, age at death, and presence of extracardiac anomalies.
  • Statistical analysis to determine incidence, associations, and frequency of organ system involvement.

Main Results:

  • Extracardiac malformations were identified in 439 (43.9%) of the 1000 children.
  • ECMs were more frequent in girls and in infants with low birthweight (≤2500 g).
  • Noncardiac anomalies were primary causes of death in one-third of cases, with alimentary, skeletal, and urogenital systems most frequently involved. Septal defects showed the highest ECM incidence, while transposition of the great arteries had the lowest.

Conclusions:

  • Significant extracardiac malformations are prevalent in children with congenital heart disease and are a major contributor to mortality.
  • Specific patterns of ECMs are associated with particular types of congenital heart defects, suggesting potential shared developmental pathways.
  • Early identification and management of ECMs are essential for improving outcomes in pediatric CHD patients.

Related Concept Videos

Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...
Cardiovascular System Abnormal Findings II: Auscultation01:25

Cardiovascular System Abnormal Findings II: Auscultation

Auscultation, an essential part of a heart examination, is done using a stethoscope. It provides crucial information about heart function and possible heart problems. Due to heart problems, abnormal sounds can be heard during systole or diastole. These sounds include S3 and S4 gallops, opening snaps, systolic clicks, and murmurs.
Abnormal Heart Sounds
Gallops:
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...